Legend Capital

Legend Capital, established in 2001, is a Beijing-based venture capital firm and subsidiary of Legend Holdings Ltd. It manages multiple funds totaling up to US$700 million, focusing on early-stage IT companies and mid-market growth stage companies in China. Its investment sectors include network applications and services, outsourcing, professional services, IC design, key components, consumer goods, clean technology, healthcare, and modern services. Legend Capital actively supports its portfolio companies, providing business resources and tailored services to facilitate growth and enhance returns. Notable portfolio companies include Joyo.com (acquired by Amazon.com) and Spreadtrum Communications (Nasdaq: SPRD).

Daqing Cai

Managing Director

Rui Chen

Managing Director

Hao Chen

Vice Chairman

Frank Hong

Managing Director

Henry Haiquan Ji

Executive Director

Yi Kang

Director

Jiaqing Li

Managing Director

Richard Li

President

Joon Sung Park

Managing Director

FAN Qihui

Executive Director

Zhenxing Shao

Partner / Managing Director

Jenking Shao

Managing Director and Partner

Piau-Voon Wang

Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Tony WANG

Managing Director and Vice President

Ge Xinyu

Managing Director

Hank Zhou

Managing Director and Co-Chief Investment Officer

Quan Zhou

Managing Director, Partner

Hongbin Zhou

Managing Director

Linan Zhu

Chairman

William Wen

Executive Director

495 past transactions

Core Medical Technology

Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Easy Flow

Series A in 2025
Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Force Inspiration

Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.

Zhongke Guosheng

Series A in 2025
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

TOPI Imaging Technology

Series E in 2025
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

X Square

Seed Round in 2025
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

AiCheng Technology

Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

DeepWise

Venture Round in 2025
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Picea Motion

Series A in 2025
Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

TBSTest

Series D in 2024
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.

Chuangrui Spectrum

Seed Round in 2024
Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Zhipu AI

Venture Round in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Angitia Biopharmaceuticals

Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to the discovery and development of innovative therapeutics targeting serious musculoskeletal diseases. The company specializes in researching and developing breakthrough therapies for conditions affecting bones, muscles, and joints. By focusing on creating novel drugs, Angitia aims to provide effective treatments that enhance patient recovery from severe musculoskeletal ailments.

Allink Biotherapeutics

Series A in 2024
Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Nuwacell

Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

Macrolux Medical

Series B in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Zhipu AI

Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Infinigence

Series A in 2024
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

RUICYCLE

Series C in 2024
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company develops innovative solutions for the recovery and regeneration of lithium battery materials, emphasizing cascade utilization and new material recycling. RUICYCLE's technologies enable an industrial ecological closed loop that ensures automatic, safe crushing of batteries, alongside zero pollution treatment and recycling solutions. Through its advanced methodologies, RUICYCLE aims to address the growing challenges associated with lithium battery waste and promote sustainability in the battery industry.

Ensurge Medical

Series A in 2024
Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.

Xellar Biosystems

Seed Round in 2024
Xellar Biosystems is a biotechnology company that focuses on enhancing drug discovery and development through the integration of artificial intelligence and machine learning with extensive wet-lab experiments. Its innovative platform provides researchers with simplified models and reductionistic tools, facilitating more efficient analysis of drug testing and treatment. By combining advanced computational techniques with hands-on laboratory research, Xellar aims to accelerate the process of discovering and testing new pharmaceuticals, ultimately contributing to advancements in medical treatments.

Volant Aerotech

Series A in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

DK Medtech

Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Chaitin Tech

Venture Round in 2024
Beijing Chaitin Tech Co., Ltd. is a technology-oriented security company focused on addressing Internet security challenges. With a highly skilled research and development team, Chaitin Tech specializes in creating customized security products and services aimed at enhancing the security capabilities of enterprises. The company develops innovative web application security solutions that protect critical assets from evolving cyber threats. By leveraging advanced technologies and methods, Chaitin Tech strives to improve domestic security levels while aligning with global standards in cybersecurity.

Zhongke Guosheng

Venture Round in 2024
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

MS ENERGY

Series D in 2024
MS Energy is a technology-focused enterprise dedicated to delivering sustainable energy solutions. It develops and deploys a Lithium battery energy storage safety system and platform, designed to facilitate the global energy internet's construction. The company's pre-diagnosis management platform offers commercialized lithium battery safety warnings and digital battery management systems, enabling industrial users to access advanced and efficient green energy services.

Dearer Medical

Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Macrolux Medical

Series A in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Sunshine Hydrogen

Series A in 2024
Sunshine Hydrogen designs and manufactures its own PWM hydrogen production power supply.

Leapstack

Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

Rhino Medical

Series A in 2023
Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Lingtai Krypton Biotechnology

Seed Round in 2023
Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to the discovery and development of innovative therapeutics targeting serious musculoskeletal diseases. The company specializes in researching and developing breakthrough therapies for conditions affecting bones, muscles, and joints. By focusing on creating novel drugs, Angitia aims to provide effective treatments that enhance patient recovery from severe musculoskeletal ailments.

Rxilient Health

Venture Round in 2023
Rxilient Health is a company that specializes in providing contract development and manufacturing organization (CDMO) services for the pharmaceutical industry. It focuses on manufacturing and distributing pharmaceutical products designed to address unmet medical needs as well as health and beauty requirements. The company offers a diverse range of professional dermatology and medical aesthetic products, emphasizing a scientific approach to skin health and aesthetics. This enables Rxilient Health to cater to a wide array of consumer demands in the realm of skincare and cosmetic solutions.

Alioth

Series A in 2023
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.

Leadrive

Series D in 2023
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

Saige Research

Series B in 2023
Saige Research is a company that specializes in developing artificial intelligence solutions tailored for industrial inspection and quality control within the manufacturing sector. It offers a deep learning vision inspection platform designed to address the challenges faced by inspectors, enhancing operational efficiency. The technology features capabilities such as power detection, speed detection, and versatility, allowing for seamless integration and development. By automating the inspection process, Saige Research aims to provide optimal AI solutions that improve product quality and streamline workflows in manufacturing environments.

Ligatech Bioscience

Series D in 2023
Ligatech Bioscience, established in 2014 and headquartered in Qingpu, China, specializes in the design, development, production, and sales of medical devices for orthopedic and sports medicine. Its product portfolio includes molecular weight polyethylene suture and striped titanium plates, along with artificial ligaments and fixation systems. The company also offers technical advice and services to its users.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

Jinqirui Biology

Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Wepure

Seed Round in 2023
Wepure develops, manufactures, and distributes nano-microspheres made of silica gel and resin.

Boyin Hearing

Series A in 2023
Boyin Hearing offers a comprehensive selection of hearing treatments for persons suffering from hearing loss.

Litecore

Venture Round in 2023
Litecore is a manufacturer of optoelectronic devices and processors for broadband, large data centers, and information security.

SpacemiT

Series A in 2023
SpacemiT is a computing chip company that specializes in the development and manufacture of advanced semiconductor solutions. It is focused on creating natively integrated cloud-edge-device architecture, with an emphasis on RISC-V high-performance CPUs. The company's offerings aim to provide robust computing solutions that combine integrated hardware and software optimization, catering to the growing demands of cloud computation and high-performance computing. SpacemiT aspires to establish itself as a pivotal player in the digital age's computing landscape, positioning itself as a significant global computing powerhouse.

Using.AI

Seed Round in 2023
Using.AI is an artificial intelligence application service provider focused on enhancing the advanced manufacturing industry through innovative technology. The company specializes in machine vision, robotics learning, and machine learning to develop self-learning solutions that optimize manufacturing processes. Its products aim to advance sectors such as OLED, optics components, and semiconductor devices, providing significant improvements in efficiency and effectiveness. By leveraging AI, Using.AI delivers cutting-edge solutions that address the evolving needs of the manufacturing landscape.

Tailan New Energy

Series B in 2023
Tailan New Energy is a company co-founded by experts in lithium battery research and development, along with a senior team specializing in industrialization. The company focuses on the technological advancements and commercialization of new solid-state lithium batteries and essential lithium battery materials. In addition to developing innovative electronic special materials and resource recycling technologies, Tailan New Energy offers a range of services including battery sales, battery leasing, and the sale of graphite and carbon products. Its commitment to emerging energy technology positions it as a significant player in the lithium battery industry.

Dipeak

Angel Round in 2023
Dipeak is a big data computing and artificial intelligence company that helps businesses traverse the AI era. Dipeak offers computer software services connected to data intelligence engines that integrate computing intelligence.

Sinsegye

Seed Round in 2023
Sinsegye is a product-driven enterprise that specializes in industrial control supercomputing infrastructure. The company develops and provides industrial intelligence computers and software aimed at enhancing industrial automation and intelligence. Its offerings are tailored to advanced manufacturing, high-end equipment manufacturing, new energy, and industrial IT innovation sectors. By focusing on these areas, Sinsegye seeks to transform the current landscape of industrial computing, equipping users with the tools necessary for modernization and efficiency in their operations.

BRC BIOTECHNOLOGY

Seed Round in 2023
BRC Biotechnology is a company focused on providing quality testing services for biopharmaceutical compliance. It supports the evaluation of biological agents and conducts quality assessments for various biopharmaceutical products, including cell and gene therapies, nucleic acid medications, and vaccines. Additionally, BRC Biotechnology is involved in research and development within the pharmaceutical sector, aiming to deliver innovative solutions and potential treatments for patients. The company's expertise extends to drug discovery and the development of diagnostic equipment, positioning it as a key player in the biotechnology industry.

CoJourney

Series A in 2023
CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.

Open Source China

Series B in 2023
Open Source China is a prominent online community focused on open source software technology. It serves as a platform for IT developers to discover, utilize, and exchange open source technologies, facilitating collaboration and innovation within the field. The community offers a variety of resources, including open source software libraries, code sharing, discussion forums, collaborative translation, and blogs. Additionally, Open Source China provides support through technical questions and answers, as well as software information services, creating an environment conducive to the development and optimization of open source technologies for domestic developers.

Chuangrui Spectrum

Angel Round in 2023
Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Bio-Engine

Series C in 2023
Bio-Engine is a company based in Shanghai, China, focused on the research and development of veterinary biological products. Founded in 2014, Bio-Engine specializes in creating and producing antibodies, recombinant proteins, and vaccines for both humans and livestock using serum-free suspension culture technology for animal cells. The company's expertise extends to providing clinical trial services for pharmaceutical manufacturers and scientific research units.

TriApex

Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

N1 Life

Seed Round in 2023
N1 Life is a biomedical company dedicated to drug discovery and the development of innovative therapeutics, particularly focusing on PDC drugs within the anti-tumor pipeline. The company aims to bridge the gap between research and clinical application by employing advanced drug delivery technologies. By leveraging disruptive innovations, N1 Life strives to transform the pharmaceutical industry, significantly reducing both the cost and timeline associated with drug development. This approach enables the healthcare sector to better address the unmet medical needs of both humans and companion animals.

Rongke Power

Series B in 2023
Rongke Power specializes in the development and manufacturing of vanadium redox flow batteries, focusing on safe and reliable energy storage solutions. The company offers a diverse range of products, including its VPower, TPower, and UPowertm lines, as well as container energy storage systems and comprehensive energy storage solutions. Rongke Power provides operation and maintenance services for power stations, empowering enterprises to create cleaner and more energy-efficient energy grids. With a commitment to independent intellectual property rights, the company positions itself as a key player in the energy storage industry.

Tripod Preclinical Research

Funding Round in 2023
Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

ZStack

Series C in 2023
ZStack is a provider of cloud computing services focused on simplifying access to cloud solutions for enterprises. The company offers a range of products, including self-developed private and hybrid cloud solutions, mini hyper-converged machines, and a cloud management platform. Its services are designed to facilitate unified management of data center resources, encompassing computing, networking, and storage. ZStack has successfully served over 2,500 enterprise users and has established partnerships with over 250 cloud vendors across various sectors, including government, finance, education, internet, energy, and manufacturing. The company's mission is to promote inclusive cloud computing by reducing the barriers associated with cloud adoption.

SJ Semi

Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

CMind-SEMI

Series A in 2023
CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.

Macrolux Medical

Series A in 2023
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

ProBio

Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Life Biosciences

Series A in 2022
Life Biosciences specializes in animal behaviour analysis services, supporting scientific research with a comprehensive suite of offerings including blood biochemistry tests, routine blood examinations, pathological staining, immunohistochemistry, molecular and cellular experiments, flow cytometry, X-ray irradiation, and nuclear magnetic resonance imaging. They also provide experimental animal model resources, large animal disease models, testing, imaging, foster care, decontamination services, further facilitating laboratory animal research within the scientific community.

PolarisIC

Seed Round in 2022
PolarisIC specializes in the development of advanced measurement and imaging chip products, utilizing cutting-edge single-photon avalanche diode (SPAD) technology. The company offers two main product lines: direct photon time-of-flight (dToF) measurement chips and low-light imaging chips. The dToF chips are designed for various applications, including height determination for unmanned aerial vehicles (UAVs), obstacle avoidance, navigation for automated guided vehicles (AGVs), and smart perception in the Internet of Things (IoT). The low-light imaging chips boast high sensitivity and pixel digitization capabilities, with potential uses in night vision systems, security monitoring, industrial measurement, and smartphone photography. PolarisIC is committed to technological innovation, excelling in dToF detection, high-speed digital processing, detection algorithm fusion, and system integration.

Zhongke Guosheng

Seed Round in 2022
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

ClinBrain

Series C in 2022
ClinBrain is a company that focuses on healthcare big data services, specifically aimed at hospitals. It has developed a hospital information integration platform that digitizes and standardizes patient data alongside medical and clinical data. This integration is designed to facilitate medical research, improving the efficiency and effectiveness of data management in healthcare settings. By streamlining access to comprehensive patient information, ClinBrain aims to enhance the overall quality of medical research and healthcare delivery.

Easy Flow

Angel Round in 2022
Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Sifli Technologies

Series A in 2022
Sifli Technologies specializes in the design and development of chips for embedded artificial intelligence and Internet of Things (IoT) applications. The company creates platforms that facilitate data collection and processing for IoT sensors, as well as inferential processing for edge artificial intelligence. Its products support a range of applications, including smart wearables, medical and health equipment, home automation, intelligent terminals, industrial instruments, and intelligent buildings. By focusing on these areas, Sifli Technologies aims to enhance the functionality and efficiency of connected devices across various industries.

GBase

Post in 2022
GBase is a provider of database software solutions based in China, specializing in the development of products tailored for various industries, including finance, telecommunications, government, energy, transportation, and national defense. The company focuses on enabling enterprises to utilize domestically developed software, which supports their operational needs and enhances data management capabilities. GBase's offerings are designed to meet the specific requirements of its clients, facilitating improved performance and efficiency in data handling across diverse sectors.

Sinsegye

Seed Round in 2022
Sinsegye is a product-driven enterprise that specializes in industrial control supercomputing infrastructure. The company develops and provides industrial intelligence computers and software aimed at enhancing industrial automation and intelligence. Its offerings are tailored to advanced manufacturing, high-end equipment manufacturing, new energy, and industrial IT innovation sectors. By focusing on these areas, Sinsegye seeks to transform the current landscape of industrial computing, equipping users with the tools necessary for modernization and efficiency in their operations.

Alioth

Series A in 2022
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.

VectorBuilder

Series C in 2022
VectorBuilder is an online platform specializing in the development and optimization of gene delivery solutions, catering to both basic research and clinical applications. The platform enables researchers to design and order custom gene delivery vectors with ease, effectively simplifying the traditionally complex processes involved in vector construction and production. VectorBuilder offers a comprehensive array of contract research organization (CRO) services, including scientific research vector customization and clinical vector preparation. Additionally, the company provides advanced capabilities in gene delivery technologies and AAV capsid engineering, supported by extensive inventories and state-of-the-art facilities that comply with Good Manufacturing Practices (GMP). By streamlining the process of vector cloning and offering personalized solutions, VectorBuilder supports advancements in life sciences and drug development.

GalaxySpace

Series D in 2022
GalaxySpace is a Chinese company established in 2016, specializing in the development and manufacturing of low Earth orbit (LEO) broadband satellite constellations and 5G communication networks. The company focuses on creating satellite internet solutions and is engaged in the research, development, and production of various communication payloads and satellite platforms. Its product offerings include microwave communication payloads, phased array antennas, power management systems, and solar panels. Additionally, GalaxySpace provides comprehensive AI-driven satellite launch services, enabling clients to access efficient communication and information services at lower costs. The company's satellite applications extend to monitoring airport traffic, parking, and oil reserves, as well as evaluating land types and uses.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

Leadrive

Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

Nuclei System Technology

Venture Round in 2022
Nuclei System Technology is a pioneering semiconductor company in China that specializes in RISC-V processor licensing. The company focuses on the development of high-performance and low-power processors, along with associated system-on-chip (SoC) platforms, tailored for a wide range of embedded system applications. Nuclei's innovative semiconductor solutions are designed for smart electronics, telecommunications, and computer processing, particularly in the context of artificial intelligence of things (AIoT) applications. By offering configurable 32/64-bit RISC-V processors, Nuclei aims to meet the increasing demands of the global market for advanced and efficient embedded technologies.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

RUICYCLE

Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company develops innovative solutions for the recovery and regeneration of lithium battery materials, emphasizing cascade utilization and new material recycling. RUICYCLE's technologies enable an industrial ecological closed loop that ensures automatic, safe crushing of batteries, alongside zero pollution treatment and recycling solutions. Through its advanced methodologies, RUICYCLE aims to address the growing challenges associated with lithium battery waste and promote sustainability in the battery industry.

CMind-SEMI

Series A in 2022
CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.

Tianfu

Series C in 2022
Nanjing Tianfu Software Co., Ltd. is a developer of custom software solutions and intelligent industrial software based in Nanjing, China. Founded in 2011, the company serves various industries, including turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. Its offerings encompass a range of technical services, such as CAE pre- and post-processing development, special solver development, industrial design platform construction, and artificial intelligence platform development. Tianfu focuses on meeting the specific needs of its clients by providing tailored software solutions that enhance efficiency and innovation across different sectors.

AKA Robotics

Series A in 2022
AKA Robotics is a developer and manufacturer of specialized and industrial robots, as well as intelligent equipment. The company focuses on creating innovative solutions for various industries, including shipbuilding, petrochemicals, wind power, and offshore platforms. Its robots are designed to perform tasks such as rust removal, cleaning, deicing, testing, spraying, and polishing, thereby providing efficient methods for maintaining and upgrading infrastructure. Through its advanced technologies, AKA Robotics aims to eliminate the need for human workers in hazardous environments characterized by high risk and pollution, while also promoting green development and facilitating enterprise transformation.

Digital Enhancement

Seed Round in 2022
Digital Enhancement, established in 2019, specializes in advancing radio frequency (RF) performance through innovative digital technologies. The company is recognized for its leading digital front end (DFE) solutions, which are designed to enhance radio linearization for 5G base stations, WiFi, and mobile devices. By utilizing a proprietary Crest Factor Reduction (CFR) and digital predistortion (DPD) algorithm, Digital Enhancement significantly improves critical RF metrics, including bandwidth, linearity, efficiency, and power amplifier output, all while maintaining cost-effectiveness. The company's solutions cater to the increasing demands for high-frequency, high-bandwidth, compact, and energy-efficient technologies, positioning it as a key player in the digital RF space.

Joymed Technology

Series B in 2022
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

TOPNC

Series D in 2022
TOPNC is a Chinese manufacturer specializing in advanced machinery for high-end industries. It focuses on developing and producing Computer Numerical Control (CNC) machine tools and precision transmission technology, serving the aerospace sector with intelligent manufacturing equipment and process solutions.

Huili Bio

Series A in 2022
Huili Bio is a next-generation synthetic biology enzyme computational design platform.

ClinChoice昆翎

Series E in 2022
ClinChoice, also known as Fountain Medical Development Ltd, is a contract research organization based in Beijing, China. The company specializes in providing comprehensive, ICH GCP compliant clinical research services to multinational clients in both China and the United States. Its offerings include consulting, project management, regulatory affairs, and clinical operations, as well as central laboratory services. ClinChoice also focuses on site management, biometrics, and designing clinical trials. Additional services encompass the collection, review, assessment, and reporting of adverse events and serious adverse events, along with data and safety monitoring board handling and signal detection services. Founded in 2006, ClinChoice has established itself as a key player in the clinical research sector.

TBSTest

Venture Round in 2022
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

Nest

Series A in 2022
Nest is a manufacturer of laboratory equipment and consumables primarily focused on the life sciences sector. The company utilizes modern production tools in a large manufacturing facility to create various products, including cytology, microbial detection, and molecular biology consumables. In addition to these offerings, Nest also provides in vitro diagnostic and medical device-related products. By continually researching and developing new fundamental supplies, Nest aims to provide affordable solutions for its customers, ensuring that laboratories have access to essential consumables for their research needs.

Tailan New Energy

Series A in 2022
Tailan New Energy is a company co-founded by experts in lithium battery research and development, along with a senior team specializing in industrialization. The company focuses on the technological advancements and commercialization of new solid-state lithium batteries and essential lithium battery materials. In addition to developing innovative electronic special materials and resource recycling technologies, Tailan New Energy offers a range of services including battery sales, battery leasing, and the sale of graphite and carbon products. Its commitment to emerging energy technology positions it as a significant player in the lithium battery industry.

Senscomm Semiconductor

Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company established in 2018 and headquartered in Suzhou, China. The company specializes in the design and development of semiconductor solutions, focusing on key technology areas such as augmented reality (AR), virtual reality (VR), the Internet of Things (IoT), and electric vehicles (EV). Since its inception, Senscomm has successfully launched over 20 products, addressing the growing global demand for innovative semiconductor technologies in these rapidly evolving markets.

Fit2Cloud

Series D in 2022
Fit2Cloud, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers across various multi-cloud environments. Fit2Cloud's offerings address critical issues related to IT operation security and continuous application delivery. Their product lineup includes a comprehensive Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these solutions, Fit2Cloud empowers enterprises to effectively manage and utilize cloud services, facilitating their digital transformation and ensuring a seamless operational experience.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Reliable Med

Series A in 2022
Reliable Med is a medical device developer focused on creating and providing clinical mass spectrometry equipment for in vitro diagnostic (IVD) tests. The company addresses a significant need in the medical industry by offering high-end clinical mass spectrometry solutions and IVD detection kits. By enhancing diagnostic capabilities, Reliable Med aims to enable healthcare professionals to diagnose patients more efficiently and accurately.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

Tichuang Biotechnology

Series A in 2022
Tichuang Biotechnology is an enterprise that realizes the industrialization and commercialization of cross-material types. Tichuang Biotechnology provides integrated solutions for production, education, and research in order to meet the needs of multiple industries for green and high-quality raw materials. Tichuang Biotechnology's strain library and component library platform advences breakthroughs in mass production and universality.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.